Inside a new study, we documented the identification along with the characterization of a new atypical opioid receptor with distinctive adverse regulatory properties in the direction of opioid peptides.1 Our results confirmed that ACKR3/CXCR7, hitherto often called an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is also a https://conolidine43111.ampedpages.com/a-review-of-conolidine-62664800